Annotation Detail

Information
Associated Genes
KIT
Associated Variants
KIT EXON 11 MUTATION
KIT EXON 11 MUTATION
Associated Disease
melanoma
Source Database
CIViC Evidence
Description
Melanoma patients with KIT mutation but not KIT amplification showed response to imatinib treatment in a small cohort of patients.
Drug
Imatinib
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/58
Gene URL
https://civic.genome.wustl.edu/links/genes/29
Variant URL
https://civic.genome.wustl.edu/links/variants/66
Rating
3
Evidence Type
Predictive
Disease
Melanoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
23775962
Drugs
Drug NameSensitivitySupported
ImatinibSensitivitytrue